乳房切除术后放疗对上臂淋巴水肿的纵向影响:基于红外光电体积测量法的上臂体积序列分析
本研究纳入2008至2016年间330例乳腺癌术后继发上臂淋巴水肿患者,采用红外光电体积测量法在淋巴水肿诊断后1至48个月序列评估上臂过度体积百分比(PEV),定义持续严重淋巴水肿(PSL)为PEV≥20%出现2次及以上。中位随访72.5个月,71例(21.5%)发生PSL。乳房切除术后放疗(PMRT)尤其区域淋巴结照射(RNI)与上臂淋巴水肿患者PEV持续增加相关,建议及时物理治疗。
要点
- PMRT尤其RNI与上臂淋巴水肿患者PEV持续增加相关
- PSL发生率为21.5%,中位随访72.5个月
- 腋窝淋巴结清扫≥20枚、淋巴水肿分期、PEV、蜂窝织炎及物理治疗依从性与PSL风险相关
核心结论
- PMRT尤其RNI与上臂淋巴水肿患者PEV持续增加相关,该人群需及时物理治疗。
研究设计与样本
- 回顾性队列分析,纳入2008至2016年间330例乳腺癌术后继发上臂淋巴水肿患者。
- 采用红外光电体积测量法在淋巴水肿诊断后1、3、6、12、18、24、36、48个月序列评估PEV。
- PSL定义为PEV≥20%出现2次及以上,采用逐步回归分析评估PSL危险因素。
主要发现
- 接受PMRT者202例(61.2%),其腋窝淋巴结清扫范围更大且淋巴水肿分期II/III期更常见(p<0.001)。
- 中位随访72.5个月,71例(21.5%)发生PSL。
- PSL患者更多接受≥20枚淋巴结清扫且未重建、淋巴水肿分期更晚、诊断时PEV更高、蜂窝织炎事件更频繁。
- PSL风险与PMRT联合RNI、腋窝淋巴结清扫≥20枚、淋巴水肿分期、诊断时PEV、蜂窝织炎及物理治疗依从性显著相关。
关键数值与推荐
- PSL定义:PEV≥20%出现2次及以上。
- PEV评估时间点:淋巴水肿诊断后1、3、6、12、18、24、36、48个月。
临床怎么用
- 对上臂淋巴水肿患者,尤其接受PMRT联合RNI者,应关注PEV序列变化并及时给予物理治疗。
- 腋窝淋巴结清扫≥20枚、淋巴水肿分期较晚、诊断时PEV较高及蜂窝织炎病史者需加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: This study was conducted to evaluate the longitudinal impact of postmastectomy radiation therapy (PMRT) on persistent severe lymphedema (PSL) using arm volume measurements by an infrared optoelectronic volumetry. MATERIALS AND METHODS: Of the patients who underwent mastectomy between 2008 and 2016, we included 330 patients with secondary arm lymphedema. Percentage of excessive volume (PEV) of the arm were serially assessed using an optoelectronic volumetry 1, 3, 6, 12, 18, 24, 36, and 48 months after the lymphedema diagnosis (Tlymh_Dx). We defined PSL as 2 or more episodes of PEV ≥ 20%. Risk factors for PSL were evaluated using stepwise regression analyses. RESULTS: Patients who received PMRT (n = 202, 61.2%) were more likely to have larger extent of axillary node dissection (AND), and frequent stage II/III lymphedema at Tlymh_Dx than those who did not receive PMRT (p < 0.001). With a median follow-up of 72.5 months, PSL occurred in 71 (21.5%) patients. Patients with PSL were more frequently treated with AND of ≥ 20 nodes without reconstruction, had advanced lymphedema stage and higher PEV at Tlymh_Dx, and more frequent events of cellulitis compared to those without PSL. The risk of developing PSL was significantly associated with PMRT with regional node irradiation (RNI), AND of ≥20 nodes, lymphedema stage, and PEV at Tlymh_Dx, cellulitis, and compliance with physical therapy. CONCLUSION: PMRT, especially RNI, was associated with a consistent increase in PEV in patients with arm lymphedema. Therefore, timely physical therapy is necessary for this patient population.
引用
- Kim N, Kim H, Hwang JH, et al. Longitudinal impact of postmastectomy radiotherapy on arm lymphedema in patients with breast cancer: An analysis of serial changes in arm volume measured by infrared optoelectronic volumetry. Radiother Oncol. 2021. PMID: 33667586. doi:10.1016/j.radonc.2021.02.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。